1-4 of 4
Daqin Mao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ZUMA-19: A Phase 1/2 Study of Axicabtagene Ciloleucel Plus Lenzilumab in Patients With Relapsed or Refractory Large B-Cell Lymphoma

Olalekan O. Oluwole, Saad S. Kenderian, Parveen Shiraz, Reem Karmali, Ran Reshef, Philip L. McCarthy, Nilanjan Ghosh, Aleksandr Lazaryan, Simone Filosto, Soumya Poddar, Daqin Mao, Andrew Peng, Adrian Kilcoyne, Myrna Nahas, Sattva S. Neelapu
Journal: Blood
Blood (2022) 140 (Supplement 1): 10318–10320.
https://doi.org/10.1182/blood-2022-167688
Published: 2022
Journal Articles

Defining Sickle Cell Disease Severity Among Adults Hospitalized with Vaso-Occlusive Crisis

Kimberly S Esham, MD, Angie Mae Rodday, PhD, Nicole Savidge, BA, Daqin Mao, PhD, Ruth Ann Weidner, MBA, MRP, Susan K Parsons, MD MRP
Journal: Blood
Blood (2018) 132 (Supplement 1): 3577.
https://doi.org/10.1182/blood-2018-99-111717
Published: 2018
Journal Articles

Opioid Utilization in Adults Hospitalized with Sickle Cell Pain Crises: An Understudied Population

Angie Mae Rodday, PhD, Kimberly S Esham, MD, Nicole S Savidge, BA, Daqin Mao, PhD, Ruth Ann Weidner, MBA, MRP, Susan K Parsons, MD MRP
Journal: Blood
Blood (2018) 132 (Supplement 1): 5884.
https://doi.org/10.1182/blood-2018-99-111386
Published: 2018
Journal Articles

Quantifying Social Disadvantage for Patients with Sickle Cell Disease: Implications for Quality of Care

Nicole Savidge, BA, Susan K Parsons, MD MRP, Daqin Mao, PhD, Ruth Ann Weidner, MBA, MRP, Kimberly S Esham, MD, Angie Mae Rodday, PhD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 317.
https://doi.org/10.1182/blood-2018-99-113558
Published: 2018